Economy
Vor Biopharma Appoints Erez Kalir as Director in Recent Board ExpansionCAMBRIDGE, Mass., January 8, 2025 ; Vor Biopharma Inc. (NYSE: VOR), a leading clinical-stage cell and genome engineering company, disclosed in an 8-K form filed with the Securitie
8 Jan 21:06 · 1 article